Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Related Articles by Review for PubMed (Select 15952959)

1.

A European perspective on the Canadian guidelines for bipolar disorder.

Vieta E, Nolen WA, Grunze H, Licht RW, Goodwin G.

Bipolar Disord. 2005;7 Suppl 3:73-6. No abstract available.

PMID:
15952959
2.

[Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: facts or artefacts?].

Hausmann A, Hörtnagl C, Walpoth M, Fuchs M, Conca A.

Neuropsychiatr. 2007;21(2):131-58. Review. German.

PMID:
17640499
3.

Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.

Fountoulakis KN, Vieta E.

Int J Neuropsychopharmacol. 2008 Nov;11(7):999-1029. doi: 10.1017/S1461145708009231. Epub 2008 Aug 28. Review.

PMID:
18752718
4.

Introduction to bipolar disorder and comorbid conditions.

Gentil V.

J Clin Psychiatry. 2008 Jan;69(1):e1. Review.

PMID:
18312028
5.

Relapse prevention in bipolar disorder: a critical review of current guidelines.

McAllister-Williams RH.

J Psychopharmacol. 2006 Mar;20(2 Suppl):12-6. Review.

PMID:
16551667
6.

Treatments in child and adolescent bipolar disorders.

Consoli A, Deniau E, Huynh C, Purper D, Cohen D.

Eur Child Adolesc Psychiatry. 2007 Apr;16(3):187-98. Epub 2006 Nov 29. Review.

PMID:
17136501
7.

[Olanzapine in the treatment of bipolar disorder].

Krüger S.

Psychiatr Prax. 2006 Mar;33 Suppl 1:S18-26. Review. German.

PMID:
16511727
8.

The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials.

Weisler RH, Cutler AJ, Ballenger JC, Post RM, Ketter TA.

CNS Spectr. 2006 Oct;11(10):788-99. Review.

PMID:
17008822
9.

Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada.

Marshall DA, Douglas PR, Drummond MF, Torrance GW, Macleod S, Manti O, Cheruvu L, Corvari R.

Pharmacoeconomics. 2008;26(6):477-95. Review.

PMID:
18489199
10.

[Lithium and bipolar disorder--a renaissance?].

Simhandl C, Mersch J.

Neuropsychiatr. 2007;21(2):121-30. Review. German.

PMID:
17640498
11.

An analysis of the efficacy of treatments for bipolar depression.

Nierenberg AA.

J Clin Psychiatry. 2008;69 Suppl 5:4-8. Review.

PMID:
19265634
12.

Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change.

Martinez-Arán A, Vieta E, Chengappa KN, Gershon S, Mullen J, Paulsson B.

Bipolar Disord. 2008 Jul;10(5):566-79. doi: 10.1111/j.1399-5618.2008.00611.x. Review.

PMID:
18657241
13.
14.

Interventions for acute mood episodes in patients with bipolar disorder.

Garlow SJ.

J Clin Psychiatry. 2008 Feb;69(2):e05. Review.

PMID:
18363449
15.

Bipolar spectrum disorder: differential diagnosis and treatment.

Muzina DJ.

Prim Care. 2007 Sep;34(3):521-50, vi. Review.

PMID:
17868758
16.
17.

Bipolar disorder: how far are we from a rigorous definition and effective management?

Emilien G, Septien L, Brisard C, Corruble E, Bourin M.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):975-96. Epub 2007 Mar 16. Review.

PMID:
17459551
18.

[Clinical standing of valproate treatment of bipolar disorders].

Grunze H, Adli M, Bauer M, Berger M, Bergmann A, Bräunig P, Bschor T, Falkai P, Gastpar M, Greil W, Kasper S, Krüger S, Laux G, Müller WE, Naber D, Walden J.

Fortschr Neurol Psychiatr. 2007 Apr;75(4):220-35. Review. German.

PMID:
17427043
19.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
20.

Polytherapy in bipolar disorder.

Lin D, Mok H, Yatham LN.

CNS Drugs. 2006;20(1):29-42. Review.

PMID:
16396522
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk